Does TOFACITINIB Cause Product prescribing issue? 235 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 235 reports of Product prescribing issue have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.2% of all adverse event reports for TOFACITINIB.
235
Reports of Product prescribing issue with TOFACITINIB
0.2%
of all TOFACITINIB reports
4
Deaths
23
Hospitalizations
How Dangerous Is Product prescribing issue From TOFACITINIB?
Of the 235 reports, 4 (1.7%) resulted in death, 23 (9.8%) required hospitalization, and 3 (1.3%) were considered life-threatening.
Is Product prescribing issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 235 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Product prescribing issue?
DUPILUMAB (1,715)
POLYETHYLENE GLYCOL 3350 (1,439)
LENALIDOMIDE (948)
OXYCODONE (646)
RIVAROXABAN (359)
ACETAMINOPHEN\OXYCODONE (347)
ETONOGESTREL (311)
ACETAMINOPHEN\HYDROCODONE (298)
CERTOLIZUMAB PEGOL (297)
CABOZANTINIB S-MALATE (294)
Which TOFACITINIB Alternatives Have Lower Product prescribing issue Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN